A community oncology pharmacist explains how seeing patients across the course of their diagnosis builds trust and why accessibility remains the field’s biggest challenge despite advances in AI.
|Videos|March 14, 2017
Access to High Cost Drugs Remains a Challenge in Specialty
Author(s)Lauren Santye, Assistant Editor
Paul LeVine, vice president of Analytic Services at Trial Card, discusses potential ways to overcome the hurdle of limited access to high cost specialty drugs.
Advertisement
Paul LeVine, vice president of Analytic Services at Trial Card, discusses potential ways to overcome the hurdle of limited access to high cost specialty drugs.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Pharmacy Times
1
AHA 2026: Pharmacists at the Center of Cardiometabolic Care
2
From Recognition to Prior Authorization: ATTR-CM Diagnosis Gaps
3
FDA Approves Perioperative Durvalumab Plus Enfortumab Vedotin-ejfv for MIBC
4
Pneumococcal Vaccines Show Moderate Immunogenicity, Strong Safety in Children With Cancer
5